The practice of risk assessment is evolving. Current approaches focus on attempts to incorporate more of the available information into weight of the evidence decisions on cancer hazard and risk. These approaches have been published within the context of the revised USEPA Guidelines for Carcinogen Risk Assessment (USEPA, 2003). These guidelines stress the importance of attempting to understand and describe how an agent induces tumors (i.e., mode of action) in determining and estimating human cancer risk. The guidelines are meant to be flexible enough to allow for the inevitable advances in the science of carcinogenesis.
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Past practice of identifying cancer hazards through toxicologic testing is being replaced by efforts to characterize hazards by evaluating mechanistic data and developing biologically based models. Hazard characterization involves the integration of empirical observations in human studies and toxicity tests with other in vivo and in vitro data in order to develop inferences regarding the biological basis for potential hazards in humans. Based on the historical premise that animal carcinogens are likely to be human carcinogens, safety assessment must now grapple with apparent paradoxes. Certain animal carcinogenicity may be irrelevant to human carcinogenicity, or certain animal carcinogens are unlikely to be human carcinogens.
To be most valuable in safety or risk assessment, incorporation of more information into carcinogen hazard characterization should:
r Allow the identification of cancer hazards by providing data on measurable biochemical or cellular endpoints which can serve as biomarkers of response for more complex adverse biological effects. Ideally, these measurable endpoints should be mechanistically linked to the effect of concern rather than simply being correlated with it.
r Provide insights into the conditions necessary for response and the shape of the dose-response relationship for effects of concern going from high to low dose. Ideally, in vitro data should be able to extend the dose response relationship established by in vivo studies to lower levels based on increased ability to detect responses in individual cells or using more sensitive techniques. The determination of an appropriate exposure or dose metric to link these data will be critical.
r Suggest targets of opportunity for further study in human populations by identifying potentially sensitive populations based on molecular or cellular characteristics or on sensitive stages in development and aging.
Biomarkers of exposure, response or susceptibility are now in use in molecular epidemiology and in clinical studies and therapeutics. Understanding cancer mode of action represents a nexus of emerging technologies and fundamental biology. The use of such approaches will assist in our understanding of cancer as a disease as well as aid in hazard and risk characterization in a regulatory and public health context. Data developed in the context of clinical trials may serve as the basis for studies of the influence of environmental agents on disease progression or susceptibility. Indicators of exposure that can be linked to biologically effective dose estimations will significantly improve our ability to predict risk and to avoid exposure misclassification, a serious problem in most epidemiologic studies. The 2 papers that follow provide excellent examples of the use of mode of action in characterizing human cancer hazard by putting animal responses in perspective.
Introduction
Understanding the mode of action of carcinogens is critical to the scientific assessment of exposure-related risk. Although convention suggests that assessment of genotoxic chemicals should be addressed using conservative assumptions of no threshold, several examples, such as vinyl acetate, exist that challenge this assumption (Hengstler et al., 2003) . Local metabolism of vinyl acetate produces DNA-reactive acetaldehyde but it also produces acetic acid and protons, which contribute to intracellular acidification, cytotoxicity and cell proliferation. This presentation reviews their relative contributions to the overall mode of action of vinyl acetate and presents quantitative descriptions of the mode of action in the form of a physiologically based pharmacokinetic model (Bogdanffy et al., 1999; Bogdanffy and Valentine, 2003) . These qualitative and quantitative approaches support the concept that the mode of carcinogenic action of vinyl acetate has practical levels of exposure below which risk is negligible.
Vinyl Cancer Bioassays
Vinyl acetate is a synthetic organic ester used in polyvinyl acetate emulsion in latex paints, adhesives, in paper and paper board coatings, and in the manufacture of polyvinyl alcohol. In 2-year inhalation bioassays, vinyl acetate induces nasal tumors in rats, but not mice, and in drinking water has been reported to produce tumors of the upper digestive tract in both rats and mice with the tumor incidence being highest in the oral cavity followed by the esophagus and forestomach. However, the exposure concentrations required to produce these effects are high: 600 ppm by inhalation or 10,000 ppm by drinking water. The dose-response curves for both tumor types are highly nonlinear and tumor appearance is preceded by induced cellular proliferation (Bogdanffy and Valentine, 2003) .
Role of Cell Proliferation in the Mode of Action
Elevated cellular proliferation is observed at concentrations associated with tumor formation. However, in both the nasal respiratory epithelium and the upper digestive tract mucosae, cellular proliferation occurs in the absence of overt cytotoxicity. Olfactory epithelium is the most sensitive of the nasal tissues to tumor formation. The proliferation response is more profound than respiratory epithelium and is accompanied by cytotoxicity characterized as degeneration of the olfactory epithelium. Thus it appears that vinyl acetate induces proliferation via both compensatory tissue regeneration and a mitogenic stimulus.
Vinyl Acetate Metabolism, Genetic Toxicology, and Cytotoxicity
Vinyl acetate is hydrolyzed via carboxylesterase to acetic acid and vinyl alcohol, which readily rearranges to yield the clastogen acetaldehyde. The genetic toxicology of vinyl acetate is nearly identical to that of acetaldehyde with the exception that vinyl acetate requires a source of carboxylesterase to induce chromosomal damage. Both materials are largely negative for point mutations but induce sister chromatid exchanges and other chromosomal aberrations. This activity is related to the weak activity of acetaldehyde as a DNA-protein crosslinking agent although cellular acidification itself has been shown to induce chromosomal aberrations and topoisomerase II-mediated DNA damage. Acetaldehyde is further oxidized via NAD + -dependent aldehyde dehydrogenase to acetic acid ultimately yielding 3 protons per molecule of vinyl acetate at physiological pH. These biotransformation pathways occur in all affected tissues although the histochemical distribution of the enzymes is an important factor in tissue susceptibility. In olfactory epithelium, carboxylesterase is localized to sustentacular cells, which are support cells for sensory neurons, and to Bowman's glands of the submucosa. Carboxylesterase is noticeably absent in the basal cells, which are proliferating, nondifferentiated progenitor cells of tumors, suggesting that exposure of basal cells to acetaldehyde must occur via diffusion from local metabolism in neighboring epithelial cells. Acetic acid has been shown to be markedly more cytotoxic to nasal tissues than acetaldehyde suggesting its formation in olfactory tissue is the cause of degeneration. Until recently it was not clear why olfactory tissue shows such marked sensitivity to the cytotoxic effects of vinyl acetate while respiratory epithelium and oral cavity mucosa appear to be relatively resistant.
